PURPOSE: To evaluate treatment of the inguinal nodes for @entity1 with @entity957 . METHODS AND MATERIALS: We reviewed the records of 227 @entity1 who had treatment of the inguinal lymph nodes between 1980 and 1998 for @entity957 . The inguinal nodes were clinically suspicious in 67 @entity1 and clinically negative in 160. Regional treatment was as follows: lymph node dissection (LND) alone in 119 @entity1 , LND plus @entity1161 ( @entity1161 ) in 57, and @entity1161 alone in 51. The extent of LND ranged from node excision to radical inguinal LND; all @entity1 treated with LND alone had at least a superficial inguinal LND. Median follow-up of surviving @entity1 was 98 months. Rates of inguinal node recurrence (INR) at 5 years were calculated using the Kaplan-Meier method. RESULTS: Thirty-two @entity1 had INRs (5-year INR rate, 15.4%). @entity1 who received @entity1161 alone or @entity1161 + LND were significantly more likely than those treated with LND alone to have T3-4 @entity5 , @entity5 >5 cm, or lymph node involvement. However, 5-year INR rates were similar for the three groups (16%, 13%, and 16%, respectively). For @entity1 who had LND only, the risk of INR was greater if the @entity5 was more than 2 cm (p = 0.056) or poorly differentiated (p = 0.04). For @entity1 who had postoperative @entity1161 , INR was significantly greater if the time from LND to @entity1161 was greater than 50 days (p = 0.03). Ten @entity1 had severe groin or @entity455 after LND. Two @entity1 died of @entity260 . Six @entity1 who were treated with @entity1161 had @entity173 or hip replacements after treatment. CONCLUSION: @entity1161 alone or in combination with LND is highly effective in preventing INR in @entity1 with @entity957 and is associated with a low risk of major late complications.

The role of XXXX in preventing regional recurrences of invasive @entity957 .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity455 :: ('MESH:D014652', 'Disease') :: ['lower-extremity complications'] @entity5 :: ('MESH:D009369', 'Disease') :: ['primary tumor', 'tumors'] @entity1161 :: ('MESH:D011832', 'Disease') :: ['radiation therapy', 'RT'] @entity957 :: ('MESH:D002294', 'Disease') :: ['squamous cell carcinoma of the vulva'] @entity260 :: ('MESH:D011183', 'Disease') :: ['postoperative cardiopulmonary complications'] @entity173 :: ('MESH:D006620', 'Disease') :: ['hip fractures']
@entity1161 :: (MESH:D011832,Disease) :: ['radiation therapy']
